QuidelOrtho beats Q2 earnings and revenue estimates, but cuts its 2026 outlook on persistent China weakness and a softer respiratory testing environment.
Zacks
More News
Integer Holdings Q2 Earnings & Revenues Top Estimates, Margins Decline
ITGR beats Q2 earnings and revenue estimates, but sales and margins decrease as product headwinds persist ahead of its $5.7B KKR deal.
Zacks
Here's Why McKesson (MCK) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
$1000 Invested In McKesson 5 Years Ago Would Be Worth This Much Today
McKesson (NYSE:MCK) has outperformed the market over the past 5 years by 23.04% on an annualized basis producing an average annual return of 34.84%. Currently, McKesson has a market capitalization of $101.38 billion.read more...
Benzinga
Will Pharma and Specialty Demand Boost Cardinal Health's Q4 Results?
Cardinal Health heads into Q4 earnings with pharma, specialty and higher-margin businesses in focus as investors watch if growth offsets pricing headwinds.